medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 2

<< Back Next >>

Med Int Mex 2013; 29 (2)

Correlation of delta uric acid and the severity of sepsis

Peralta-Prado AB, Ramírez-Hinojosa JP, Ramírez-Polo AI, López-Aguilar CE, Maya-Romero H, Carrillo-Esper R
Full text How to cite this article

Language: Spanish
References: 23
Page: 154-158
PDF size: 374.09 Kb.


Key words:

Uric acid, sepsis, septic shock, APACHE II, SOFA.

ABSTRACT

Background: Sepsis is a major cause of morbidity and mortality. Biomarkers helps for the diagnosis and monitoring of sepsis, uric acid (UA) is an accessible and unexpensive biomarker.
Objective: this work is to determine the correlation of delta uric acid with the severity of sepsis.
Material and method: We performed an analytical study, open, prospective and longitudinal in patients over 18 who met criteria for sepsis as the campaign to implement the survival of sepsis, we excluded patients with a history of gout, with parenteral nutrition or diet rich in amino acids hyperproteic. For statistical analysis, analytical and statistical tests using Pearson correlation.
Results: We included 38 patients aged 19-85 years (m = 50), 53% (n = 20) were men and 47% (n = 18) women. The main diagnoses were pneumonia and soft tissue infection. The AU group decreased APACHE II ‹20 (3.9) and ≥20 (3.1) (p = 0.012). The delta 3.3mg/dL AU was in the group of septic shock vs. 1.7mg/dL in the sepsis group (p = 0.045).
Conclusions: The delta UA is an accesible and unexpensive marker and to assess the severity and mortality of sepsis.


REFERENCES

  1. Landry DW, Oliver JA. The Pathogenesis of vasodilatory shock. N Engl J Med 2001;345:587-595.

  2. Pascual C, Karzai W, Meier-Hellmann A, Oberhoffer M, Horn A, Bredle D, et al. Total plasma antioxidant capacity is not always decreased in sepsis. Crit Care Med 1998;26:705-709.

  3. Berg RM, Moller K, Bailey DM. Neuro-oxidative-nitrosative stress in sepsis. J Cereb Blood Flow Metab 2011;31:1532-1544.

  4. Huet O, Dupic L, Harrois A, Duranteau J. Oxidative stress and endothelial dysfunction during sepsis. Front Biosci 2011;1:1986-1995.

  5. Waring WS, Convery A, Mishra V,Shenkin A, Webb DJ, Maxwell SR. Uric acid reduces exercise-induced oxidative stress in healthy adults. Clin Sci 2003;105:425-430.

  6. Victor VM, Rocha M, Esplugues JV, De la Fuente M. Role of free radicals in sepsis: antioxidant therapy. Curr Pharm Des 2005;11:3141-3158

  7. Leaver HA, Yap PL, Rogers P, Wright I, Smith G, Williams PE, et al. Peroxides in human leukocytes in acute septic shock: a preliminary study of acute phase changes and mortality. Eur J Clin Invest 1995;25:777-783.

  8. Choi HK, Ford E. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007;120:442-447.

  9. Adamopoulos D, Vlassopoulos C, Seitanides B, Contoyiannis P, Vassilopoulos P. The relationship of sex steroids to uric acid levels in plasma and urine. Acta Endocrinol 1977;85: 198-208.

  10. Meneshian A, Bulkley GB. The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction. Microcirculation 2002; 9:161-175.

  11. Ventetuolo CE, Levy MM. Cardiac Biomarkers in the Critically ill. Crit Care Clin 2011; 27:327-343.

  12. Abou-Mourad NN, Chamberlain BE, Ackerman NB. Poor prognosis of patients with intra-abdominal sepsis and hypouricemia. Surg Gynecol Obstet 1979;148:358-360.

  13. Tsai K, Hsu TG, Kong CW, Lin K, Lu F. Is the endogenous peroxyl-radical scavenging capacity of plasma protective in systemic inflammatory disorders in humans? Free Rad Biol Med 2000;28:926-933.

  14. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.

  15. Chuang CC, Shiesh SC, Chi CH, Tu YF, Hor LI, Shieh CC, et al. Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis. Critical Care 2006;10:1-7.

  16. MacKinnon KL, Molnar Z, Lowe D, Watson ID, Shearer E. Measures of total free radical activity in critically ill patients. Clin Biochem 1999;32:263-268.

  17. Jabs CM, Sigurdsson GH, Neglen P. Plasma levels of high energy compounds compared with severity of illness in critically ill patients in the intensive care unit. Surgery 1998;124:65-72.

  18. Galley HF, Davies MJ Webster NR. Xantine oxidase activity and free radical generation in patients with sepsis syndrome. Crit Care Med 1996;24:1649-1653

  19. Victor VM, Rocha M, De la Fuente M. Immune cells: free radicals and antioxidants in sepsis International Immunopharmacology 2004;4:327-347.

  20. Giovannini I, Chiarla C, Giuliante F, Vellone M, Ardito F, et al. Biochemical and clinical correlates of hypouricemia in surgical and critically ill patients. Clin Chem Lab Med 2007; 45:1207-1210.

  21. Wu VC, Huang JW, Hsuch PR, Yang YF, Tsai HB, et al. Renal hypouricemia is an ominous sign in patients wth severe acute respiratory syndrome. Am J Kidney Dis 2005; 45:88-95.

  22. Vander Werf BD, Watt J, Joseph B, Wynne J, Kulvatunyou N, O’Keeffe T, et al. Can plasma B-type natriuretic peptide levels predict need for mechanical ventilation after injury?. The American Journal of Surgery 2010; 200:845–850.

  23. Giovannini I, Chiarla C, Giuliante F, Pallavicini F, Vellone M, Ardito F, et al. Serum uric acid, creatinine, and the assessment of antioxidant capacity in critical illness. Critical Care 2006; 10(5):421.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2013;29